Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology. 2005 Mar 08; 64(5):934; author reply 934.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.